TORNIAI, MARIANGELA
 Distribuzione geografica
Continente #
NA - Nord America 2.397
EU - Europa 918
AS - Asia 869
SA - Sud America 142
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 67
OC - Oceania 1
Totale 4.472
Nazione #
US - Stati Uniti d'America 2.364
SG - Singapore 304
IT - Italia 170
CN - Cina 163
VN - Vietnam 157
RU - Federazione Russa 153
BR - Brasile 113
DE - Germania 99
UA - Ucraina 91
IE - Irlanda 80
SE - Svezia 75
FI - Finlandia 64
HK - Hong Kong 64
FR - Francia 53
TR - Turchia 52
CI - Costa d'Avorio 42
GB - Regno Unito 39
BD - Bangladesh 34
IN - India 29
DK - Danimarca 26
CA - Canada 21
KR - Corea 16
BE - Belgio 15
MA - Marocco 15
PL - Polonia 14
AR - Argentina 13
JP - Giappone 12
NL - Olanda 12
ZA - Sudafrica 11
ES - Italia 9
IQ - Iraq 6
MX - Messico 6
LT - Lituania 5
CO - Colombia 4
AZ - Azerbaigian 3
CL - Cile 3
EC - Ecuador 3
ID - Indonesia 3
KE - Kenya 3
PH - Filippine 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
SN - Senegal 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CM - Camerun 1
CY - Cipro 1
DZ - Algeria 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MN - Mongolia 1
NG - Nigeria 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 4.405
Città #
Ashburn 441
Singapore 224
Chandler 218
Fairfield 139
Jacksonville 131
Des Moines 113
San Jose 103
New York 84
Dublin 80
Wilmington 74
Boardman 68
Hong Kong 63
Woodbridge 58
Seattle 57
Los Angeles 55
Houston 54
Ho Chi Minh City 50
Cambridge 49
Beijing 48
Dallas 46
Abidjan 42
Council Bluffs 41
The Dalles 38
Ann Arbor 37
Munich 36
Hanoi 33
Turku 32
Lawrence 31
Princeton 31
Turin 31
San Mateo 30
Lauterbourg 28
Moscow 28
Orem 19
Helsinki 18
Washington 16
Milan 15
Santa Clara 15
Brussels 14
Chicago 14
San Diego 14
Warsaw 14
Buffalo 13
São Paulo 13
Chennai 12
Frankfurt am Main 12
Montreal 11
Centro 10
Columbus 10
Hefei 10
London 10
Tokyo 10
Da Nang 9
Falls Church 9
Haiphong 9
Pune 9
Shanghai 8
Brooklyn 7
Hải Dương 7
Johannesburg 7
Norwalk 7
Phoenix 7
Amsterdam 6
Ancona 6
Denver 6
Guangzhou 6
Kilburn 6
Miano 6
Poplar 6
Rome 6
Ankara 5
Paris 5
Atlanta 4
Guarulhos 4
Istanbul 4
Manchester 4
Pittsburgh 4
Rio de Janeiro 4
Urbisaglia 4
Baghdad 3
Baku 3
Charlotte 3
City of London 3
Cleveland 3
Jiaxing 3
Montegiorgio 3
Mumbai 3
Nairobi 3
Quito 3
Salt Lake City 3
Salvador 3
Wuxi 3
Điện Bàn 3
Ấp Tháp Mười 3
Anápolis 2
Baytown 2
Boston 2
Bến Tre 2
Campos dos Goytacazes 2
Casablanca 2
Totale 3.065
Nome #
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 211
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 194
Gender Differences and Outcomes in Melanoma Patients 164
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 163
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 162
Electrolyte disorders in cancer patients: a systematic review 161
Benefits and limitations of a multidisciplinary approach in cancer patient management 153
High CTLA-4 expression correlates with poor prognosis in thymoma patients 151
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 149
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 149
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 149
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 147
Gender differences and outcome of melanoma patients 145
Systemic treatment for lung carcinoids: from bench to bedside 145
Hyponatremia in cancer patients: Time for a new approach 143
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 143
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 142
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues 142
Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms 141
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 137
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 135
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 130
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: A multicenter retrospective analysis 129
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 129
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: An insight from clinical practice 124
Gastro-entero-pancreatic neuroendocrine tumors: Is now time for a new approach? 122
Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors 121
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 116
Medical Treatment in Gastroenteropancreatic Neuroendocrine Neoplasms: a look into the future. 115
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study 109
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes 101
Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET) 50
Totale 4.472
Categoria #
all - tutte 20.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022246 16 36 14 3 7 30 11 12 28 24 25 40
2022/2023666 40 78 42 58 30 165 0 35 128 4 70 16
2023/2024360 51 6 31 22 48 107 7 25 1 15 1 46
2024/2025589 71 53 17 4 41 31 52 25 103 27 78 87
2025/20261.687 153 77 54 190 206 131 300 158 127 165 47 79
2026/202771 71 0 0 0 0 0 0 0 0 0 0 0
Totale 4.472